For neurotransmitter analysis, ESA says its HPLC systems offer the highest sensitivity available today for monoamines, amino acids, and oxidative stress-related analysis
ESA Biosciences showcased with sister company Dynex Technologies its latest products for brain research at Neuroscience 2005.
The Society for Neuroscience's 35th annual meeting was held at the Washington Convention Centre in Washington, DC (USA), from 12-16 November 2005.
"ESA is a well-known name in neuroscience," said Magellan president and CEO, Robert Rosenthal.
"Some of the most-important discoveries in brain research have been made with ESA electrochemical detectors, which are ideal where the need for high-sensitivity analysis is of paramount importance: for example, measuring neurotransmitters and modulators such as dopamine, norephinephrine, serotonin, GABA, and acetylcholine.
"However, neuroscientists may be less familiar with the Dynex product lines, which use the most sophisticated detection, liquid handling, and plate-manipulation technologies to deliver the optimum combination of performance and value.
"Our mission at Magellan is to be recognised worldwide as a provider of innovative, high-quality products that improve outcomes from discovery to diagnostics.
"With the combined resources of ESA, Dynex, and Magellan, we believe we can solve additional analytical challenges for neuroscience customers".
For neurotransmitter analysis, ESA says its HPLC systems offer the highest sensitivity available today for monoamines, amino acids, and oxidative stress-related analysis.
For in vivo voltammetry, the new BioStat multimode potentiostat enables real-time, in vivo measurement of nitric oxide, while the EL-400 is the benchmark for fast cyclic voltammetry.
For lipid analysis, the award-winning Corona Cad lets researchers quantitate lipids using HPLC without the cost and complexity of MS.
Dynex Technologies offers a range of absorbance, fluorescence, and luminescence microplate readers and automation systems designed for the latest neurobiology applications: gene and protein expression; enzyme activity; receptor/ligand binding; ion-channel measurements; signal-transduction assays; and neural cell growth and development.
Founded in 1968, ESA Bioscience enables answers to the most-pressing applications challenges by delivering unique and valuable analytical systems, HPLC instruments, advanced detectors, related components and reagents, as well as services to the analytical laboratory and clinical point-of-care setting.
ESA is a wholly owned subsidiary of Magellan Bioscience.
Magellan Biosciences develops point-of-care products, related consumables, laboratory instruments, and automated systems for clinical diagnostics and biomedical research worldwide.
